COVID-19 shone a bright light on life sciences with unprecedented results—enterprises getting the new COVID-19 vaccine to market in less than a year. Life sciences enterprises’ ability to create new life-saving therapies, sophisticated medical devices, and other health vehicles continues to be astounding. That progress, however, has been possible because of an ecosystem approach that includes technology and service providers, academia, startups, and various other stakeholders.
In the HFS Horizons: Life Science Service Providers, 2023 study, we evaluated 29 service providers for their ability to address the cost (Horizon 1), experience (Horizon 2), and health outcomes (Horizon 3) for health consumers globally.
Note: All service providers within a Horizon are listed alphabetically.
Source: HFS Research, 2023
To read the rest of the research, click the download button below.
Watch this HFS Videocast on the HFS Horizons: Life Science Service Providers, 2023
Register now for immediate access of HFS' research, data and forward looking trends.
Get Started
If you don't have an account, Register here |
Register now for immediate access of HFS' research, data and forward looking trends.
Get Started